Pat Cotroneo
2018
In 2018, Pat Cotroneo earned a total compensation of $3.6M as Chief Financial Officer at FibroGen, a 29% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $294,281 |
|---|---|
| Option Awards | $1,283,583 |
| Salary | $471,000 |
| Stock Awards | $1,505,000 |
| Other | $17,662 |
| Total | $3,571,526 |
Cotroneo received $1.5M in stock awards, accounting for 42% of the total pay in 2018.
Cotroneo also received $294.3K in non-equity incentive plan, $1.3M in option awards, $471K in salary and $17.7K in other compensation.
Rankings
In 2018, Pat Cotroneo's compensation ranked 3,174th out of 14,244 executives tracked by ExecPay. In other words, Cotroneo earned more than 77.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,174 out of 14,244 | 78th |
Division Manufacturing | 1,178 out of 5,759 | 80th |
Major group Chemicals And Allied Products | 410 out of 2,122 | 81st |
Industry group Drugs | 339 out of 1,811 | 81st |
Industry Pharmaceutical Preparations | 260 out of 1,385 | 81st |
Pay ratio
| Pat Cotroneo's Pay | $3,571,526 |
|---|---|
| Median Employee's Pay | $212,858 |
| Pay Ratio | 17to 1 |
In 2018, the annual total compensation of Pat Cotroneo was $3,571,526.
The annual total compensation of the median employee at FibroGen was $212,858.
The ratio of Pat Cotroneo's pay to the pay of median employee was therefore 17 to one.
Source: SEC filing on April 23, 2019.
Cotroneo's colleagues
We found two more compensation records of executives who worked with Pat Cotroneo at FibroGen in 2018.